Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · cited 1×
“…neurotropic factor, as well as impaired endogenous opioid function, changes in GABAergic and/or glutamatergic transmission , cytokine or steroidal alterations, and abnormal circadian rhythm (Antonijevic, 2006; Hindmarch, 2001; Plotsky et al., 1998; Raison et al., 2006; Ressler and Nemeroff, 2000).”
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
Synergy and other interactions in phytomedicines
WILLIAMSON, E. (2001) · Phytomedicine · doi:10.1078/0944-7113-00060 · Cited by 1,004
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Plotsky, P. M., Owens, M. J., & Nemeroff, C. B. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70006-x · Cited by 672 · cited 1×
“…neurotropic factor, as well as impaired endogenous opioid function, changes in GABAergic and/or glutamatergic transmission , cytokine or steroidal alterations, and abnormal circadian rhythm (Antonijevic, 2006; Hindmarch, 2001; Plotsky et al., 1998; Raison et al., 2006; Ressler and Nemeroff, 2000).”
Kessler, R. C., Soukup, J., Davis, R. B., Foster, D. F., Wilkey, S. A., Van Rompay, M. I., & Eisenberg, D. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.289 · Cited by 656
Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine
Rege, N. N., Thatte, U. M., & Dahanukar, S. A. (1999) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199906)13:4<275::aid-ptr510>3.0.co;2-s · Cited by 488
Hypericum Depression Trial Study Group (2002) · JAMA · doi:10.1001/jama.287.14.1807 · Cited by 480
St John's wort for major depression
Linde, K., Berner, M. M., & Kriston, L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000448.pub3 · Cited by 477
Jordan, S. A., Cunningham, D. G., & Marles, R. J. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.12.005 · Cited by 415 · cited 1×
“Epigenetic assays showed that the gene expression profile of the whole formula was unique, and did not reflect the effects from the individual herbs (Jordan et al., 2010).”
Tyrer, P., & Baldwin, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69865-6 · Cited by 404
Valerian for Sleep: A Systematic Review and Meta-Analysis
Bent, S., Padula, A., Moore, D., Patterson, M., & Mehling, W. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.026 · Cited by 387 · cited 6×
“Meta-analyses and reviews by Bent et al. (2006) and Fernandez-San-Martin et al. (2010) reveal that the evidence concerning the soporific plant medicine is quite varied, and currently does not support its use in treating insomnia.”
InfluentialMechanism of Action of St John???s Wort in Depression: What is Known?
Butterweck, V. (2003) · CNS Drugs · doi:10.2165/00023210-200317080-00001 · Cited by 369
Saffron in phytotherapy: Pharmacology and clinical uses
Schmidt, M., Betti, G., & Hensel, A. (2007) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-007-0428-4 · Cited by 365 · cited 2×
“This reflects traditional knowledge of adverse reactions (Schmidt et al., 2007).”
Viola, H., Wasowski, C., Levi de Stein, M., Wolfman, C., Silveira, R., Dajas, F., Medina, J., & Paladini, A. (1995) · Planta Medica · doi:10.1055/s-2006-958058 · Cited by 365
Savelev, S., Okello, E., Perry, N. S. L., Wilkins, R. M., & Perry, E. K. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00125-4 · Cited by 364
Insomnia: Epidemiology, characteristics, and consequences
Roth, T., & Roehrs, T. (2003) · Clinical Cornerstone · doi:10.1016/s1098-3597(03)90031-7 · Cited by 359
Bhattacharya, S. K., & Muruganandam, A. V. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00110-2 · Cited by 344 · cited 3×
“maze, social interaction and feeding latency in an unfamiliar environment tests) (Bhattacharya et al., 2000; Bhattacharya and Muruganandam, 2003; Mehta et al., 1991) 2,3 2,3 3 Anxiety”
C., S., P., N., J., L., J., C., C., H., L., D., & T., R. (2001) · Psychopharmacology · doi:10.1007/s002130100815 · Cited by 342 · cited 2×
“monniera is considered beneficial in treating cognitive insufficiency; (Stough et al., 2001) E.”
Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla
Avallone, R., Zanoli, P., Puia, G., Kleinschnitz, M., Schreier, P., & Baraldi, M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00264-1 · Cited by 336
Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study
Bhattacharya, S. K., Bhattacharya, A., Sairam, K., & Ghosal, S. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80030-6 · Cited by 331
A systematic review of insomnia and complementary medicine
Sarris, J., & Byrne, G. J. (2011) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2010.04.001 · Cited by 328
Self-citationFundamentals of Pharmacognosy and Phytotherapy
Heinrich, M., Kinghorn, A. D., epilogue, J. D. P., Maizels, I. B. D., & Gibbons, S. (2004) · UCL Discovery (University College London) · Cited by 313
Noorbala, A. A., Akhondzadeh, S., Tahmacebi-Pour, N., & Jamshidi, A. H. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.11.004 · Cited by 311
Akhondzadeh, S., Fallah-Pour, H., Afkham, K., Jamshidi, A.-H., & Khalighi-Cigaroudi, F. (2004) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-4-12 · Cited by 307
Akhondzadeh, S., Tahmacebi‐Pour, N., Noorbala, A., Amini, H., Fallah‐Pour, H., Jamshidi, A., & Khani, M. (2005) · Phytotherapy Research · doi:10.1002/ptr.1647 · Cited by 298 · cited 12×
“The Akhondzadeh et al. (2005) RCT using the stamen had a large effect size of d = 1.51, while the Moshiri et al. (2006) study which used the cheaper petals revealed a similar large effect size of d = 1.78.”
InfluentialBacopa monniera Linn. as an antioxidant: mechanism of action.
Tripathi, Y. B., Chaurasia, S., Tripathi, E., Upadhyay, A., & Dubey, G. (1996) · PubMed · Cited by 286
Principles and Practice of Phytotherapy
(2013) · Elsevier eBooks · doi:10.1016/c2009-0-48725-7 · Cited by 281
Hosseinzadeh, H., & Noraei, N. B. (2009) · Phytotherapy Research · doi:10.1002/ptr.2597 · Cited by 270
Akhondzadeh, S., Naghavi, H. R., Vazirian, M., Shayeganpour, A., Rashidi, H., & Khani, M. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00367.x · Cited by 268
Potential medicinal plants for CNS disorders: an overview
Kumar, V. (2006) · Phytotherapy Research · doi:10.1002/ptr.1970 · Cited by 268
Comer, J. S., Olfson, M., & Mojtabai, R. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.07.007 · Cited by 252
Kennedy, D. O., Scholey, A. B., Tildesley, N. T. J., Perry, E. K., & Wesnes, K. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00777-3 · Cited by 249
Self-citationAkhondzadeh Basti, A., Moshiri, E., Noorbala, A.-A., Jamshidi, A.-H., Abbasi, S. H., & Akhondzadeh, S. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.010 · Cited by 247
Singer, A., Wonnemann, M., & Müller, W. E. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35043-8 · Cited by 243
Moshiri, E., Basti, A. A., Noorbala, A.-A., Jamshidi, A.-H., Hesameddin Abbasi, S., & Akhondzadeh, S. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.08.006 · Cited by 237
Perry, N., & Perry, E. (2006) · CNS Drugs · doi:10.2165/00023210-200620040-00001 · Cited by 234
Sairam, K., Dorababu, M., Goel, R. K., & Bhattacharya, S. K. (2002) · Phytomedicine · doi:10.1078/0944-7113-00116 · Cited by 231
Behavioral characterisation of the flavonoids apigenin and chrysin
Zanoli, P., Avallone, R., & Baraldi, M. (2000) · Fitoterapia · doi:10.1016/s0367-326x(00)00186-6 · Cited by 224
Dang, H., Chen, Y., Liu, X., Wang, Q., Wang, L., Jia, W., & Wang, Y. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.020 · Cited by 223
Amsterdam, J. D., Li, Y., Soeller, I., Rockwell, K., Mao, J. J., & Shults, J. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ac935c · Cited by 218 · cited 3×
“Chamomile (Matricaria recutita) (Amsterdam et al., 2009) Anxiety: 8-week RCT (n=57) using standardised Chamomile extract (220mg-1100mg of titrated, depending on response) vs.”
InfluentialClinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
Darbinyan, V., Aslanyan, G., Amroyan, E., Gabrielyan, E., Malmström, C., & Panossian, A. (2007) · Nordic Journal of Psychiatry · doi:10.1080/08039480701643290 · Cited by 216
Self-citationDepressive disorders—is it time to endorse different pathophysiologies?
Antonijevic, I. A. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.004 · Cited by 210
Limpeanchob, N., Jaipan, S., Rattanakaruna, S., Phrompittayarat, W., & Ingkaninan, K. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.07.039 · Cited by 206
Kava extract versus placebo for treating anxiety
Pittler, M. H., & Ernst, E. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003383 · Cited by 204
CARDIOVASCULAR PROTECTION BY GINSENOSIDES AND THEIR NITRIC OXIDE RELEASING ACTION
Chen, X. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb01767.x · Cited by 203
Kennedy, D. O., Little, W., & Scholey, A. B. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000132877.72833.71 · Cited by 199
Self-citationPanossian, A., & Wikman, G. (2009) · Current Clinical Pharmacology · doi:10.2174/157488409789375311 · Cited by 197
Self-citationInsomnia: Pathophysiology and implications for treatment
Roth, T., Roehrs, T., & Pies, R. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.06.002 · Cited by 196
Monoamine oxidase inhibition by Rhodiola rosea L. roots
van Diermen, D., Marston, A., Bravo, J., Reist, M., Carrupt, P.-A., & Hostettmann, K. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.01.007 · Cited by 194
Anti-anxiety studies on extracts of Passiflora incarnata Linneaus
Dhawan, K., Kumar, S., & Sharma, A. (2001) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(01)00339-7 · Cited by 192
Sateia, M. J., & Nowell, P. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17480-1 · Cited by 190
St. John's wort: Role of active compounds for its mechanism of action and efficacy
Butterweck, V., & Schmidt, M. (2007) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-007-0440-8 · Cited by 189
Effectiveness of Valerian on insomnia: A meta-analysis of randomized placebo-controlled trials
Fernández-San-Martín, M. I., Masa-Font, R., Palacios-Soler, L., Sancho-Gómez, P., Calbó-Caldentey, C., & Flores-Mateo, G. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.12.009 · Cited by 187
Drug interactions with St. Johns Wort (Hypericum perforatum): a review of the clinical evidence
Izzo, A. A. (2004) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp42139 · Cited by 186
Atsumi, T., & Tonosaki, K. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2005.12.012 · Cited by 186
Application of the “-Omic-” technologies in phytomedicine
Ulrich-Merzenich, G., Zeitler, H., Jobst, D., Panek, D., Vetter, H., & Wagner, H. (2007) · Phytomedicine · doi:10.1016/j.phymed.2006.11.011 · Cited by 184
Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review
Lakhan, S. E., & Vieira, K. F. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-42 · Cited by 181
Benke, D., Barberis, A., Kopp, S., Altmann, K.-H., Schubiger, M., Vogt, K. E., Rudolph, U., & Möhler, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.013 · Cited by 179
Hypnotic effect of jujubosides from Semen Ziziphi Spinosae
Cao, J.-X., Zhang, Q.-Y., Cui, S.-Y., Cui, X.-Y., Zhang, J., Zhang, Y.-H., Bai, Y.-J., & Zhao, Y.-Y. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.03.023 · Cited by 176
Perfumi, M., & Mattioli, L. (2007) · Phytotherapy Research · doi:10.1002/ptr.2013 · Cited by 176
Awad, R., Muhammad, A., Durst, T., Trudeau, V. L., & Arnason, J. T. (2009) · Phytotherapy Research · doi:10.1002/ptr.2712 · Cited by 175
Wijeweera, P., Arnason, J. T., Koszycki, D., & Merali, Z. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.01.011 · Cited by 171
Awad, R., Levac, D., Cybulska, P., Merali, Z., Trudeau, V. L., & Arnason, J. T. (2007) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y07-083 · Cited by 167
Akhondzadeh, S., Kashani, L., Fotouhi, A., Jarvandi, S., Mobaseri, M., Moin, M., Khani, M., Jamshidi, A. H., Baghalian, K., & Taghizadeh, M. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00342-1 · Cited by 166
Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro
Dietz, B. M., Mahady, G. B., Pauli, G. F., & Farnsworth, N. R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.009 · Cited by 166
Herbal medicines in the treatment of psychiatric disorders: a systematic review
Sarris, J. (2007) · Phytotherapy Research · doi:10.1002/ptr.2187 · Cited by 164 · cited 9×
“Mechanisms of action for herbal medicines used for treatment of psychiatric disorders primarily involve modulation of neuronal communication, via specific plant metabolites binding to neurotransmitter/neuromodulator receptors (Spinella, 2001), and via alteration of neurotransmitter synthesis and general function (Sarr…”
InfluentialSelf-citationAwad, R., Arnason, J. T., Trudeau, V. L., Bergeron, C., Budzinski, J. W., Foster, B. C., & Merali, Z. (2003) · Phytomedicine · doi:10.1078/0944-7113-00374 · Cited by 164
Hypothalamic-pituitary-adrenal axis
Honour, J. W. (1994) · Respiratory Medicine · doi:10.1016/s0954-6111(05)80035-6 · Cited by 164
Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze
Bradley, B. F., Starkey, N. J., Brown, S. L., & Lea, R. W. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.12.021 · Cited by 163
Hyperforin in St. John’s wort drug interactions
Madabushi, R., Frank, B., Drewelow, B., Derendorf, H., & Butterweck, V. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0096-0 · Cited by 162
Scholey, A. B., Tildesley, N. T. J., Ballard, C. G., Wesnes, K. A., Tasker, A., Perry, E. K., & Kennedy, D. O. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1101-3 · Cited by 162
Self-citationValeriana officinalis root extracts have potent anxiolytic effects in laboratory rats
Murphy, K., Kubin, Z. J., Shepherd, J. N., & Ettinger, R. H. (2010) · Phytomedicine · doi:10.1016/j.phymed.2009.10.020 · Cited by 158
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression
Kasper, S. F., Caraci, F., Forti, B., Drago, F., & Aguglia, E. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.07.005 · Cited by 158
Management of Patients With Treatment-Resistant Depression
Thase, M. E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0308e08 · Cited by 158
JUSSOFIE, A., Schmiz, A., & Hiemke, C. (1994) · Psychopharmacology · doi:10.1007/bf02247480 · Cited by 158
Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology
Sarris, J., LaPorte, E., & Schweitzer, I. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.522554 · Cited by 158
Self-citationAnxiolytic effects of lavender oil inhalation on open-field behaviour in rats
Shaw, D., Annett, J. M., Doherty, B., & Leslie, J. C. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.03.007 · Cited by 158
Neuroprotective and Neurological Properties of Melissa officinalis
López, V., Martín, S., Gómez-Serranillos, M. P., Carretero, M. E., Jäger, A. K., & Calvo, M. I. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9981-0 · Cited by 154
Woelk, H., Arnoldt, K., Kieser, M., & Hoerr, R. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.004 · Cited by 149
Expanding the horizons of depression: beyond the monoamine hypothesis
Hindmarch, I. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.288 · Cited by 148
Effect of lavender aroma on salivary endocrinological stress markers
Toda, M., & Morimoto, K. (2008) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2008.04.002 · Cited by 147
Ngan, A., & Conduit, R. (2011) · Phytotherapy Research · doi:10.1002/ptr.3400 · Cited by 146
Movafegh, A., Alizadeh, R., Hajimohamadi, F., Esfehani, F., & Nejatfar, M. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318172c3f9 · Cited by 143
Salgueiro, J. B., Ardenghi, P. G., Dias, M., Ferreira, M. B. C., Izquierdo, I., & Medina, J. H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00054-3 · Cited by 142
Hypericum Perforatum: A ???Modern??? Herbal Antidepressant
Wurglics, M., & Schubert‐Zsilavecz, M. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645050-00002 · Cited by 142
Discontinuation symptoms in depression and anxiety disorders
Baldwin, D. S., Montgomery, S. A., Nil, R., & Lader, M. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006358 · Cited by 140 · cited 2×
“…side effects in comparison to conventional pharmacotherapies such as antidepressants (cholinergic symptoms, sexual dysfunction, insomnia, and withdrawal issues) and benzodiazepines (somnolence, dependence and withdrawal issues) (Baldwin et al., 2007; Papakostas, 2008; Schweitzer et al., 2009).”
Tang, W., & Eisenbrand, G. (1992) · Springer eBooks · doi:10.1007/978-3-642-73739-8_50 · Cited by 140
Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy?
Wermuth, C. G. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03213-1 · Cited by 138
Complementary and Alternative Medicine Use by Psychiatric Inpatients
Elkins, G., Rajab, M. H., & Marcus, J. (2005) · Psychological Reports · doi:10.2466/pr0.96.1.163-166 · Cited by 133
Evidence-based pharmacotherapy of Generalized Anxiety Disorder
Baldwin, D. S., & Polkinghorn, C. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004870 · Cited by 129
Sexual Side-Effects of Contemporary Antidepressants: Review
Schweitzer, I., Maguire, K., & Ng, C. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903107575 · Cited by 128
Self-citationOrtíz, J. G., Nieves-Natal, J., & Chavez, P. I. (1999) · Neurochemical Research · doi:10.1023/a:1022576405534 · Cited by 127
Kava and St. John's Wort: Current Evidence for Use in Mood and Anxiety Disorders
Sarris, J., & Kavanagh, D. J. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0066 · Cited by 123
Self-citationGeneralized anxiety disorder: comorbidity, comparative biology and treatment
Nutt, D. J., Ballenger, J. C., Sheehan, D., & Wittchen, H.-U. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003048 · Cited by 122
Sarris, J., Kavanagh, D. J., Byrne, G., Bone, K. M., Adams, J., & Deed, G. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1549-9 · Cited by 121
Self-citationUebelhack, R., Franke, L., & Schewe, H.-J. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979325 · Cited by 121
The effect of St John’s wort extracts on CYP3A: a systematic review of prospective clinical trials
Whitten, D. L., Myers, S. P., Hawrelak, J. A., & Wohlmuth, H. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02755.x · Cited by 120
Anxiolytic activity of Panax ginseng roots: an experimental study
Bhattacharya, S., & Mitra, S. (1991) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(91)90193-h · Cited by 119
Hanus, M., Lafon, J., & Mathieu, M. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125002603 · Cited by 118
Kava hepatotoxicity. A clinical review
Teschke, R. (2010) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31634-5 · Cited by 118
Bradwejn, J., Zhou, Y., Koszycki, D., & Shlik, J. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00015 · Cited by 113
Rolland, A., Fleurentin, J., Lanhers, M., Younos, C., Misslin, R., Mortier, F., & Pelt, J. M. (1991) · Planta Medica · doi:10.1055/s-2006-960076 · Cited by 112
Kava Pyrones and Resin: Studies on GABAA, GABAB and Benzodiazepine Binding Sites in Rodent Brain
Davies, L. P., Drew, C. A., Duffield, P., Johnston, G. A. R., & Jamieson, D. D. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb00530.x · Cited by 110
Grundmann, O., Wang, J., McGregor, G. P., & Butterweck, V. (2008) · Planta Medica · doi:10.1055/s-0028-1088322 · Cited by 107
Anxiolytic activity of aerial and underground parts of Passiflora incarnata
Dhawan, K., Kumar, S., & Sharma, A. (2001) · Fitoterapia · doi:10.1016/s0367-326x(01)00322-7 · Cited by 105
Evaluation of herbal medicinal products : perspectives on quality, safety and efficacy
Mukherje, P. K., & Houghton, P. J. (2009) · Cited by 105
Müller, S.-M., & Klement, S. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.01.013 · Cited by 104
Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice
Rabbani, M., Sajjadi, S. E., Vaseghi, G., & Jafarian‐Dehkordi, A. (2004) · Fitoterapia · doi:10.1016/j.fitote.2004.04.004 · Cited by 102
Lechtenberg, M., Schepmann, D., Niehues, M., Hellenbrand, N., Wünsch, B., & Hensel, A. (2008) · Planta Medica · doi:10.1055/s-2008-1074535 · Cited by 102
Rahimi, R., Nikfar, S., & Abdollahi, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.018 · Cited by 101
Sarris, J. J., Kavanagh, D. J., & Byrne, G. J. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.06.003 · Cited by 97
Self-citationComparative study of Rhodiola preparations on behavioral despair of rats
Panossian, A., NIKOYAN, N. A., Ohanyan, N., Hovhannisyan, A., Abrahamyan, H., Gabrielyan, E. S., & Wikman, G. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.10.003 · Cited by 96
Self-citationChen, Q. G., Zeng, Y., Qu, Z. Q., Tang, J. Y., Qin, Y., Chung, P., Wong, R., & Hägg, U. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.03.011 · Cited by 94
Abourashed, E. A., Koetter, U., & Brattström, A. (2004) · Phytomedicine · doi:10.1016/j.phymed.2004.03.005 · Cited by 92
Mattioli, L., Funari, C., & Perfumi, M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108089872 · Cited by 91 · cited 2×
“⋄ 5-HT 1A receptor binding affinity ⋄ 5-HT 2c receptor binding affinity ⋄ Antidepressant, anxiolytic effects in animal models (elevated plus maze and tail suspension tests) ⋄ Significantly decreased sleep latency and increased sleep duration in pentobarbital-induced sleep (Cao et al., 2010; Cho et al., 2010; Jung et a…”
Benefits and Risks of Antipsychotic Polypharmacy: An Evidence-Based Review of the Literature
Tranulis, C., Skalli, L., Lalonde, P., Nicole, L., & Stip, É. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00002 · Cited by 89
St John??s wort versus placebo in obsessive???compulsive disorder: results from a double-blind study
Kobak, K. A., Taylor, L. V. H., Bystritsky, A., Kohlenberg, C. J., Greist, J. H., Tucker, P., Warner, G., Futterer, R., & Vapnik, T. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200511000-00003 · Cited by 88
Sayyah, M., Sayyah, M., & Kamalinejad, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.10.005 · Cited by 83
Cho, S.-M., Shimizu, M., Lee, C. J., Han, D.-S., Jung, C.-K., Jo, J.-H., & Kim, Y.-M. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.08.009 · Cited by 81
Modulation of GABAA Receptors by Valerian Extracts is Related to the Content of Valerenic Acid
Trauner, G., Khom, S., Baburin, I., Benedek, B., Hering, S., & Kopp, B. (2008) · Planta Medica · doi:10.1055/s-2007-993761 · Cited by 81
Panossian, A., Hambardzumyan, M., Hovhanissyan, A., & Wikman, G. (2007) · PubMed Central · Cited by 79
Self-citationPassiflora for anxiety disorder
Miyasaka, L. S., Atallah, Á. N., & Soares, B. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004518.pub2 · Cited by 78
Pharmacological effects of Withania somnifera root extract on GABAA receptor complex.
Mehta, A. K., Binkley, P. A., Ss, G., & Ticku, M. K. (1991) · PubMed · Cited by 77
Major Depression and Mental Health Care Utilization in Canada: 1994 to 2000
Patten, S. B., & Beck, C. A. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900505 · Cited by 75
Kim, D.-H., Moon, Y.-S., Jung, J., Min, S.-K., Son, B.-K., Suh, H., & Song, D. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00300-8 · Cited by 73
Witte, S., Loew, D., & Gaus, W. (2005) · Phytotherapy Research · doi:10.1002/ptr.1609 · Cited by 73
Joo, S. S., Won, T., & Lee, D. I. (2005) · Planta Medica · doi:10.1055/s-2005-864145 · Cited by 68
Efficacy of aqueous extract of Echium amoenum in treatment of obsessive–compulsive disorder
Sayyah, M., Boostani, H., Pakseresht, S., & Malayeri, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.021 · Cited by 67
Influence of Genuine Kavapyrone Enantiomers on the GABA A Binding Site
Boonen, G., & Häberlein, H. (1998) · Planta Medica · doi:10.1055/s-2006-957502 · Cited by 65
An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers.
Wolfson, P. E., & Hoffmann, D. L. (2003) · PubMed · Cited by 64
Wong, M.-L., O'Kirwan, F., HANNESTAD, J., Irizarry, K. J. L., Elashoff, D. A., & Licinio, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001470 · Cited by 63
Kim, J. H., Kim, S. Y., Lee, S., & Jang, C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.03.018 · Cited by 62
Kasper, S. F., Volz, H., Möller, H. ‐., Dienel, A., & Kieser, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.006 · Cited by 61
Neurophysiological Effects of an Extract of Eschscholzia californica Cham. (Papaveraceae)
Rolland, A., Fleurentin, J., Lanhers, M., Misslin, R., & Mortier, F. (2001) · Phytotherapy Research · doi:10.1002/ptr.884 · Cited by 59
Magura, E. I., Kopanitsa, M. V., Gleitz, J., Peters, T., & Krishtal, O. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00177-2 · Cited by 58
Kasper, S. F., Gastpar, M., Möller, H., Müller, W. E., Volz, H., Dienel, A., & Kieser, M. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328335dc1a · Cited by 58
Krishnakumar, A., Nandhu, M. S., & Paulose, C. S. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.07.031 · Cited by 56
St. John's Wort Versus Placebo in Social Phobia: Results From a Placebo-Controlled Pilot Study
Kobak, K. A., Taylor, L. V. H., Warner, G., & Futterer, R. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150227.61501.00 · Cited by 55
Panossian, A., Hambardzumyan, M., Hovhanissyan, A., & Wikman, G. (2007) · Drug Target Insights · doi:10.1177/117739280700200011 · Cited by 55
Self-citationMüller, D., Pfeil, T. A., & von den Driesch, V. (2003) · Phytomedicine · doi:10.1078/1433-187x-00305 · Cited by 54
A placebo-controlled study of Kava kava in generalized anxiety disorder
Connor, K. M., & Davidson, J. R. T. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200207000-00005 · Cited by 53
The Psychopharmacology of Herbal Medicine: Plant Drugs That Alter Mind, Brain, and Behavior
Spinella, M. (2001) · Cited by 53
Pharmacotherapy of Comorbid Mood, Anxiety, and Substance Use Disorders
Brady, K. T., & Verduin, M. L. (2005) · Substance Use & Misuse · doi:10.1080/10826080500294924 · Cited by 52
Current perspectives on the diagnosis and treatment of major depressive disorder.
Nierenberg, A. A. (2001) · PubMed · Cited by 49
How Effective Is St. John’s Wort? The Evidence Revisited
Werneke, U., Horn, O., & Taylor, D. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0504 · Cited by 48
Chang, Y., & Wang, S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.035 · Cited by 46
Phytotherapy and psychiatry: Bibliometric study of the scientific literature from the last 20 years
García-García, P., Lopez-Munoz, F. J., Rubio, G., Martín-Águeda, B., & Álamo, C. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.04.014 · Cited by 42
Dhawan, K., Kumar, S., & Sharma, A. (2002) · The Journal of Alternative and Complementary Medicine · doi:10.1089/10755530260127970 · Cited by 42
Kava, the anxiolytic herb: back to basics to prevent liver injury?
Teschke, R., Sarris, J. J., Glass, X., & Schulze, J. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03775.x · Cited by 41
Self-citationSarris, J. J., Kavanagh, D. J., Deed, G., & Bone, K. M. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.994 · Cited by 39
Self-citationFundamentals of pharmacognosy and phytotherapy
Ferro, V. D. O. (2004) · Revista Brasileira De Ciencias Farmaceuticas · doi:10.1590/s1516-93322004000300027 · Cited by 38
Butterweck, V., Brattström, A., Grundmann, O., & Koetter, U. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.4.0009 · Cited by 36
Effect of chronic treatment on 5-hydroxytryptamine receptors in rat brain
Jung, J. W., Cho, J., AHN, N., OH, H., KIM, S., Jang, C., & RYU, J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.03.014 · Cited by 33
Grundmann, O., Grundmann, O., Wähling, C., Wähling, C., Staiger, C., Staiger, C., Butterweck, V., & Butterweck, V. (2009) · Die Pharmazie · doi:10.31083/ph.2008.8753 · Cited by 31
Re-introduction of Kava(Piper methysticum)to the EU: Is There a Way Forward?
Sarris, J. J., Teschke, R., Stough, C. K. K., Scholey, A. B., & Schweitzer, I. (2010) · Planta Medica · doi:10.1055/s-0030-1250290 · Cited by 31
Self-citationThe psychopharmacology of herbal extracts: issues and challenges
Scholey, A. B., Kennedy, D. O., & Wesnes, K. A. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2062-9 · Cited by 29
Self-citationA Case of Mania Induced by Hyperlcum
Fahmi, M., Huang, C., & Schweitzer, I. (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150602 · Cited by 27
Self-citationA proteomic investigation of similarities between conventional and herbal antidepressant treatments
Pennington, K., Föcking, M., McManus, C., Pariante, C. M., Dunn, M., & Cotter, D. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108091075 · Cited by 26
Brattström, A. (2007) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-007-0442-6 · Cited by 19
Pharmacological studies of water extract of the Zizyphus seed and the Zizyphus seed containing drug
Morishita, S., Mishima, Y., Hirai, Y., Saito, T., & Shoji, M. (1987) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(87)90037-1 · Cited by 17
Franklin, M., Hafizi, S., Reed, A. S., Hockney, R. A., & Murck, H. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-931472 · Cited by 17
Hsieh, M., Chen, H., Kao, H.-C., & Shibuya, T. (1986) · PubMed · Cited by 15
Studies on the suanzaorentang in the treatment of anxiety
Chen, H.-C., Hsieh, M., & Lai, E. (1985) · Psychopharmacology · doi:10.1007/bf00429670 · Cited by 10
(2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-3132-8.x0001-1 · Cited by 8
Effects of Suanzaorentang on behavior changes and central monoamines.
Mt, H., Hc, C., Ph, H., & Shibuya, T. (1986) · PubMed · Cited by 5
(2000) · doi:10.1002/1520-6394(2000)12:1+<2::aid-da2>3.0.co;2-4
Cited by
Treatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“Kava preparations appeared to have some beneficial effects in patients with generalised anxiety disorder but have been withdrawn in many countries due to potential hepatotoxic effects [IV] (Sarris et al., 2011a).”
BackgroundPanossian, A. G., Efferth, T., Shikov, A. N., Pozharitskaya, O. N., Kuchta, K., Mukherjee, P. K., Banerjee, S., Heinrich, M., Wu, W., Guo, D., et al. (2021) · Medicinal Research Reviews · doi:10.1002/med.21743 · Cited by 347
“Furthermore, the efficacy of adaptogens in mild and moderate depression has been demonstrated.(275,355,358,360,363,366) The prophylactic use of adaptogens seems to be justified in healthy subjects for preventing aging‐related diseases, and to attenuate stress‐induced harmful effects.”
BackgroundSelf-citationRavindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660290 · Cited by 337
“Formulations of SJW have varied widely, as has the dose range (500 to 1800 mg/day), while treatment duration has spanned 4 to 12 weeks.(58,60) Since 2009, 2 systematic reviews(60,61) have confirmed the comparable efficacy of SJW to antidepressants and superiority to placebo for mild to moderate MDD (Suppl.”
BackgroundYeung, K. S., Hernandez, M., Mao, J. J., Haviland, I., & Gubili, J. (2018) · Phytotherapy Research · doi:10.1002/ptr.6033 · Cited by 229
“Previous reviews have documented herbal remedies for the treatment of depression and/or anxiety (Farah et al., 2016; Zeng et al., 2017; Muszynska et al., 2015; Bandelow et al., 2015; Sarris et al., 2011; Lakhan and Vieira, 2010; Ernst, 2006).”
Background
Metadata
- Authors
- Sarris, J., Panossian, A., Schweitzer, I., Stough, C., & Scholey, A.
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 21
- Issue
- 12
- Pages
- 841-860
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2053491126
- Cited by
- 469
- References
- 171
- FWCI
- 59.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.